Akoya (AKYA) Company Short-Term Debt

Corporate company logo of akoyabio.com (AKYA)

Akoya Biosciences (AKYA) is recognized as an authoritative expert in precision oncology diagnostics, a name associated with impeccable tissue analysis reliability. Leveraging the unique PhenoCycler, the company provides a detailed overview of tumor cellular structures to enhance immunotherapy. This chart illustrating the share price dynamics with the 0.00 indicator is presented below. The business relies on a synthesis of software and hardware, offsetting narrow specialization through stable sales of essential reagents.

AKYA Akoya Biosciences Short-Term Debt (07/04/2022 - 07/19/2025)

Akoya Biosciences Inc (AKYA) - metric breakdowns and financial figures

- stock price and consensus target price:
Stock Price Akoya|AKYA - Analyst Target Range
- market capitalization details:
Market Value Akoya Biosciences, Inc.|AKYA - Business Value
- shareholders' equity book value data:
Net Assets per Single Share Akoya Biosciences|AKYA - Total Stockholders' Equity|Market Value to Book Value Ratio akoyabio.com|AKYA - Company Total Asset Base
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Akoya Biosciences|AKYA - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Akoya|AKYA - Company Total Debt Obligations|Debts to Book Capitalization Akoya Biosciences, Inc.|AKYA - Company Long-Term Liabilities|Company Current Liabilities Akoya Biosciences|Quick Liquidity akoyabio.com
- earnings and multiples data:
AKYA - Net Income
Fundamental company analysis:akoyabio.com (AKYA)
Flagship merchandise of Akoya Biosciences Inc

Akoya Biosciences (AKYA) maintains a strong position in diagnostics due to its in-house reagent synthesis combined with partial imports of components. An analysis of total short-term debt allows for an assessment of obligations due within a year, which is critical for understanding liquidity when procuring optics and microchips, reflecting the balance between financial stability and the pace of business growth.

Competitor analysis

Abbott - Company Short-Term Debts|Short-Term Indebtedness Thermo Fisher Scientific Inc. (TMO)|GE Healthcare Corp (GEHC) - Company Short-Term Debt|Company Short-Term Indebtedness MTD|Company Short-Term Debt Waters Corporation|Short-Term Debt bio-techne.com TECH|Company Short-Term Debt Bruker (BRKR)|Short-Term Debt Volume Azenta Inc|Varex - Company Current Liabilities|Amount of Current Liabilities SMLR (Semler)|Butterfly Network, Inc. - Company Short-Term Debts|Short-Term Debt Volume mesalabs.com MLAB|QSI: Company Short-Term Debts|Company Current Liabilities Nano-X Imaging|Company Current Liabilities QTRX|MASS: Company Short-Term Loans and Borrowings|Company Short-Term Debt CapsoVision Inc (CV)|Company Current Liabilities maxcyte.com MXCT|Company Short-Term Debts RPID (Rapid Micro Biosystems, Inc.)|Seer Inc (SEER) - Short-Term Debt|Hyperfine Corp - Company Short-Term Debts|FONR (FONAR Corporation Inc) - Company Short-Term Indebtedness|DXR: Company Short-Term Debts|MDAI - Short-Term Debt Volume|VIVS (Organovo Holdings) - Company Short-Term Debts|Company Current Liabilities Aclarion Inc (ACON)|Company Short-Term Debts THMO|Company Short-Term Debts talis.bio (TLIS)|Company Short-Term Debt T2 Biosystems, Inc. TTOO